Xu D - Search Results

1

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Jiang Z, Liu J, Xu D, Macdonald L; AI463023 Study Group. Yao G, et al. Among authors: xu d. Hepatol Int. 2007 Sep;1(3):365-72. doi: 10.1007/s12072-007-9009-2. Epub 2007 Jul 31. Hepatol Int. 2007. PMID: 19669331 Free PMC article.

2

Efficacy and safety of entecavir compared to lamivudine in nucleoside-naïve patients with chronic hepatitis B: a randomized double-blind trial in China.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Jiang Z, Liu J, Xu D, Macdonald L; AI463023 Study Group. Yao G, et al. Among authors: xu d. Hepatol Int. 2008 Mar;2(1):136. doi: 10.1007/s12072-007-9043-0. Hepatol Int. 2008. PMID: 19669291 Free PMC article. No abstract available.

3

Virologic, serologic, and biochemical outcomes through 2 years of treatment with entecavir and lamivudine in nucleoside-naïve Chinese patients with chronic hepatitis B: a randomized, multicenter study.

Yao G, Chen C, Lu W, Ren H, Tan D, Wang Y, Xu D, Liu J, Xu D, Llamoso C. Yao G, et al. Among authors: xu d. Hepatol Int. 2008 Dec;2(4):486-93. doi: 10.1007/s12072-008-9088-8. Epub 2008 Aug 30. Hepatol Int. 2008. PMID: 19669324 Free PMC article.

4

Entecavir for the treatment of lamivudine-refractory chronic hepatitis B patients in China.

Yao G, Zhou X, Xu D, Wang B, Ren H, Liu J, Xu D, Macdonald L. Yao G, et al. Among authors: xu d. Hepatol Int. 2007 Sep;1(3):373-81. doi: 10.1007/s12072-007-9016-3. Epub 2007 Oct 4. Hepatol Int. 2007. PMID: 19669332 Free PMC article.

5

A multicenter, randomized, controlled trial of interferon alfacon-1 compared with alpha-2a-interferon in Chinese patients with chronic hepatitis C virus infection.

Yao GB, Fu XX, Tian GS, Xu DZ, Hao LJ, Huangfu YS, Su CX. Yao GB, et al. Among authors: xu dz. J Gastroenterol Hepatol. 2000 Oct;15(10):1165-70. doi: 10.1046/j.1440-1746.2000.02307.x. J Gastroenterol Hepatol. 2000. PMID: 11106097 Clinical Trial.

6

Virological, serological and biochemical outcomes through 3 years of entecavir treatment in nucleoside-naive Chinese chronic hepatitis B patients.

Yao GB, Ren H, Xu DZ, Zhou XQ, Jia JD, Wang YM, Chen CW. Yao GB, et al. Among authors: xu dz. J Viral Hepat. 2010 Mar;17 Suppl 1:51-8. doi: 10.1111/j.1365-2893.2010.01271.x. J Viral Hepat. 2010. PMID: 20586934 Clinical Trial.

7

Long-term efficacy of recombinant interferon alpha 2a in the treatment of chronic hepatitis C: a randomized prospective study comparing two dose schedules in Chinese patients.

Yao GB, Ji YY, Xu DZ, Gao J, Wu XH, Zhang QB, Hu DC. Yao GB, et al. Among authors: xu dz. Hepatogastroenterology. 1999 Mar-Apr;46(26):1059-64. Hepatogastroenterology. 1999. PMID: 10370667 Clinical Trial.

8

Long-term monitoring shows hepatitis B virus resistance to entecavir in nucleoside-naïve patients is rare through 5 years of therapy.

Tenney DJ, Rose RE, Baldick CJ, Pokornowski KA, Eggers BJ, Fang J, Wichroski MJ, Xu D, Yang J, Wilber RB, Colonno RJ. Tenney DJ, et al. Among authors: xu d. Hepatology. 2009 May;49(5):1503-14. doi: 10.1002/hep.22841. Hepatology. 2009. PMID: 19280622

9

Peginterferon lambda for the treatment of HBeAg-positive chronic hepatitis B: A randomized phase 2b study (LIRA-B).

Chan HLY, Ahn SH, Chang TT, Peng CY, Wong D, Coffin CS, Lim SG, Chen PJ, Janssen HLA, Marcellin P, Serfaty L, Zeuzem S, Cohen D, Critelli L, Xu D, Wind-Rotolo M, Cooney E; LIRA-B Study Team. Chan HLY, et al. Among authors: xu d. J Hepatol. 2016 May;64(5):1011-1019. doi: 10.1016/j.jhep.2015.12.018. Epub 2015 Dec 29. J Hepatol. 2016. PMID: 26739688 Clinical Trial.

10

A randomized phase 2b study of peginterferon lambda-1a for the treatment of chronic HCV infection.

Muir AJ, Arora S, Everson G, Flisiak R, George J, Ghalib R, Gordon SC, Gray T, Greenbloom S, Hassanein T, Hillson J, Horga MA, Jacobson IM, Jeffers L, Kowdley KV, Lawitz E, Lueth S, Rodriguez-Torres M, Rustgi V, Shemanski L, Shiffman ML, Srinivasan S, Vargas HE, Vierling JM, Xu D, Lopez-Talavera JC, Zeuzem S; EMERGE study group. Muir AJ, et al. Among authors: xu d. J Hepatol. 2014 Dec;61(6):1238-46. doi: 10.1016/j.jhep.2014.07.022. Epub 2014 Jul 24. J Hepatol. 2014. PMID: 25064437 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16,900 results

Search Page